课题基金 / 基金详情

Metabolic Complication of HIV Infection

Metabolic Complication of HIV Infection
HIV 感染的代谢并发症
批准号:
7225237
负责人:
Judith S. Currier
金额:
$14.56万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2009-02-28

项目摘要

项目成果

Judith S. Currier的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在接下来的5年里,我的职业目标包括(1)进行艾滋病毒疾病的流行病学和代谢并发症的影响的原创性研究,(2)开发一个全面的计划,以指导学员与职业兴趣,以病人为导向的研究,(3)我的研究计划的扩展,包括国际组成部分。加州大学洛杉矶分校正在进行的关于艾滋病毒感染的基础和临床研究的丰富多样性以及临床艾滋病研究和教育中心的设施提供了巨大的资源,以提高我作为临床研究者的经验,并为我的学员提供了一个激励的氛围。K24奖将帮助我实现我的职业目标,为我提供大量受保护的时间,用于指导我的学员,为自己获得生物统计学方面的额外培训,并专注于我自己的研究计划。本申请描述了一个全面的培训计划,研究员,其中包括在生物统计学和临床研究方法的正式培训。此外,还介绍了四个研究项目。拟议的研究将调查一组长期HAART患者的胰岛素抵抗自然史,并详细研究参与代谢并发症横断面研究的男性和女性胰岛素抵抗和脂质异常患病率的性别差异。一项前瞻性、匹配、队列研究将比较接受蛋白酶抑制剂治疗或未接受治疗的HIV感染患者与未感染HIV的患者之间的颈动脉内膜中层厚度测量值,以检验蛋白酶抑制剂治疗与亚临床动脉粥样硬化风险增加相关的假设。一项随机临床试验比较了三种抗逆转录病毒治疗方案,这些方案在世界各地资源匮乏的12个地点招募的受试者中进行,这将提供一个机会来检查与免疫重建综合征发展相关的因素,并确定这些综合征是否预示着HAART反应的改变。我的部门主管和部门主任的大力支持,使我能够减少我的临床和行政责任,这将大大有助于我成功实现我的目标。
英文摘要
DESCRIPTION (provided by applicant): Over the next 5 years my career goals include (1) conducting original research on the epidemiology and impact of metabolic complications of HIV disease, (2) developing a comprehensive program to mentor trainees with career interests in patient-oriented research, (3) the expansion of my research program to include an international component. The rich diversity of ongoing basic and clinical research on HIV infection at UCLA and the facilities available in the Center for Clinical AIDS Research and Education provide tremendous resources to enhance my experience as a clinical investigator and provide a stimulating atmosphere for my trainees. The K24 Award will help me to achieve my career goals by providing me with a significant amount of protected time to devote to mentoring my trainees, gaining additional training for myself in biostatistics and focusing on my own research program. This application describes a comprehensive training program for fellows, which includes formal training in biostatistics and clinical research methods. In addition four research projects are described. The proposed research will investigate the natural history of insulin resistance among a cohort of well-characterized patients on long term HAART and examine in detail gender differences in prevalence of insulin resistance and lipid abnormalities in men and women enrolled in a cross-sectional study of metabolic complications. A prospective, matched, cohort study will compare measurements of carotid intima medial thickness between patients with HIV infection treated with a protease inhibitor or no therapy to patients without HIV infection in order to test the hypothesis that protease inhibitor therapy is associated with an increased risk of subclinical atherosclerosis. A randomized clinical trial comparing three antiretroviral regimens among subjects enrolled at twelve sites located in resource poor settings around the world will provide the opportunity to examine the factors associated with the development of immune reconstitution syndromes and to determine whether these syndromes predict an altered response to HAART. The strong support from my Division Chief and Department Chair to allow me to reduce my clinical and administrative responsibilities will greatly facilitate my success in achieving my goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
UCLA-CDU CFAR
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: